Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Cartilage Imaging Techniques Move Toward Earlier Detection
February 2026
Novel cartilage imaging methodologies are sharpening identification of joint damage, and monitoring response in rheumatic diseases.
Read more
9 Apr 2025
New Criteria Improve Diagnosis of IgG4-Related Arterial Disease
Healthcare professionals in the U.S. are closely watching progress in the diagnosis and management of IgG4-related periaortitis, periarteritis, and retroperitoneal fibrosis, a complex subset of IgG4-related disease (IgG4-RD) that mimics other conditions and defies simple diagnostic approaches.
7 Apr 2025
Skin Thickening Rate Signals Cardiopulmonary Risk
A new prospective cohort study has found that the rate of skin thickening progression in patients with systemic sclerosis (SSc), measured using the modified Rodnan skin score (mRSS), is closely correlated with the early onset of serious cardiopulmonary complications, including interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH).
4 Apr 2025
Exploring the Effects of Nutrition on Juvenile Arthritis: One-Year Study Results
A new study examining the long-term effects of a specific carbohydrate diet (SCD) in children with juvenile idiopathic arthritis (JIA) suggests potential benefits, particularly for individuals seeking to avoid medication escalation.
2 Apr 2025
AI Improves Vasculitis Detection to 97% According to New Findings
AI is making significant strides in the diagnosis and outcome prediction of vasculitides, rare inflammatory disorders that can be challenging to identify due to their diverse clinical presentations.
28 Mar 2025
How Juvenile Arthritis Disrupts Puberty in Children
Children with juvenile idiopathic arthritis (JIA) face more than just joint pain, emerging research reveals that the condition may significantly delay puberty.
26 Mar 2025
Adipose Stem Cells: Transforming Care in Systemic Sclerosis
Adipose-derived stem cells (ADSCs) may offer a groundbreaking new approach to treating systemic sclerosis (SSc), according to a recent study.
24 Mar 2025
Nintedanib May Slow Lung Function Decline in SSc-ILD
A recent analysis of the SENSCIS and SENSCIS-ON trials has demonstrated that nintedanib effectively slows the decline in forced vital capacity (FVC) among patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).
21 Mar 2025
Medical Cannabis Linked to Hypermobility-Associated Chronic Pain Relief
A recent study conducted with the UK Medical Cannabis Registry evaluated the impact of cannabis-based medicinal products (CBMPs) on patients suffering from chronic pain due to hypermobility spectrum disorder (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS).
19 Mar 2025
How AI is Changing Kawasaki Disease Diagnosis
AI is emerging as a promising tool in the diagnosis and management of vasculitides, a group of rare inflammatory disorders that pose significant diagnostic challenges.
17 Mar 2025
How Reliable Is the New Scleroderma Skin Questionnaire?
The psychometric properties of the Scleroderma Skin Questionnaire (SSQ), a novel patient-reported outcome (PRO) designed to assess skin disease in patients with systemic sclerosis (SSc), has been evaluated in a new study.
14 Mar 2025
Cancer Outcomes in Rheumatoid Arthritis: Increased Mortality Rates
A recent long-term population study from Western Australia has revealed critical insights into the relationship between rheumatoid arthritis (RA) and cancer outcomes.
12 Mar 2025
Comparing Immunosuppressants: What Works Best in Systemic Sclerosis?
A recent analysis from the RESOLVE-1 trial has highlighted the potential of mycophenolate mofetil (MMF) in treating diffuse cutaneous systemic sclerosis (dcSSc), particularly in early-stage disease.
5 Mar 2025
Reducing Heart Risks in Arthritis: The Role of TNF Inhibitors
Inflammation is increasingly recognized as a pivotal factor in the development of atherosclerosis and its associated thrombotic complications.
26 Feb 2025
RA Drugs Show Promise Despite Kidney Issues
Explore the efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease, highlighting potential risks like deep vein thrombosis.
21 Feb 2025
GERD Symptoms Linked to Worse RA Outcomes
Gastroesophageal (GE) symptoms, such as acid reflux and heartburn, are significantly associated with higher disease activity in patients with rheumatoid arthritis (RA), according to a new study.
19 Feb 2025
What Are Best Next Steps After JAKi Failure?
For patients with rheumatoid arthritis (RA) with an inadequate response to Janus kinase inhibitors (JAKi), new research suggests that cycling to another JAKi may be more effective than switching to a biologic disease-modifying anti-rheumatic drug (bDMARD).
15 Feb 2025
Cardiovascular Imaging Breakthroughs for Rheumatic Disease
A recent study evaluated the advantages and limitations of various noninvasive imaging modalities in diagnosing cardiovascular disease (CVD) in patients with autoimmune rheumatic diseases (ARDs).
10 Feb 2025
Study Reveals Bone Erosion Patterns in Sjögren's
A recent cross-sectional study conducted at a quaternary hospital in Brazil has provided new insights into joint involvement in Sjögren’s disease (SjD), challenging its traditional classification as a non-erosive condition.
6 Feb 2025
A Game-Changer for Precision Medicine in Rheumatoid Arthritis
The potential of high-content imaging as a game-changer for precision medicine in rheumatoid arthritis (RA) has been highlighted in a new study.
31 Jan 2025
Ketogenic Diet May Exacerbate Osteoarthritis and Pain
A ketogenic diet (KD) may worsen osteoarthritis (OA) severity and increase pain sensitivity according to the results of a new study.
29 Jan 2025
Immune Checkpoint Inhibitors: A Balancing Act
Risks of autoimmune conditions (ACs) in patients treated with immune checkpoint inhibitors (ICIs), a critical class of cancer immunotherapies, have been explored in a new epidemiological study.
24 Jan 2025
Lifestyle Care Favored Over Guidelines for Back Pain
A recent randomized clinical trial has demonstrated that incorporating healthy lifestyle care into chronic low back pain management can provide small but meaningful improvements in disability, weight loss, and quality of life.
22 Jan 2025
How Air Quality Impacts Autoimmune Health
A genetic link between air pollution exposure and the risk of developing autoimmune diseases such as rheumatoid arthritis (RA), lupus, and psoriasis, has been identified in a new study.
20 Jan 2025
Dynamic Frailty Trends in Systemic Sclerosis
Frailty, a dynamic and clinically significant condition, is prevalent among patients with systemic sclerosis (SSc), according to a recently published study.
17 Jan 2025
Bridging Psoriatic Arthritis Communication Barriers
The way patients and clinicians prioritize different aspects of psoriatic arthritis (PsA) has been revealed in a new study that shed light on important disparities that could impact care quality and outcomes.
15 Jan 2025
Salivary Biomarkers Aid in Sjögren’s Detection
A diagnostic model has been developed for primary Sjögren’s disease (pSjD), utilizing salivary biomarkers, serum autoantibodies, and Schirmer’s test.
10 Jan 2025
Medication-Free Remission in Juvenile Dermatomyositis
Achieving medication-free remission (MFR) is a critical milestone in the treatment of juvenile dermatomyositis (JDM), a rare inflammatory disease primarily affecting skin and muscles.
8 Jan 2025
Exploring Botulinum Toxin for Raynaud’s Treatment
Botulinum toxin (BTX), widely known for its cosmetic and neurological applications, is emerging as a potential treatment for Raynaud’s phenomenon (RP), particularly when secondary to scleroderma.
6 Jan 2025
Premature Rheumatoid Arthritis Death Surge in Native Americans
Native Americans experience the highest premature mortality rates from rheumatoid arthritis (RA) in the United States, according to a comprehensive study analyzing national data from 1999 to 2020.
1 Jan 2025
TNF Inhibitors Lower Fracture Risk in Axial Spondylarthritis
TNF inhibitors reduce fracture risk in axial spondyloarthritis, offering protection against complications from chronic inflammation.
29 Dec 2024
Study Highlights Cancer Risks and Outcomes for Rheumatoid Arthritis Patients
A new study from Western Australia reveals that while patients with rheumatoid arthritis (RA) have a lower overall cancer incidence compared to the general population, they face higher risks for lung and hematological cancers.
20 Dec 2024
Axial Spondyloarthritis More Severe in Black Americans
A recent study conducted across five centers in Shelby County, Tennessee, reveals concerning disparities in the diagnosis and severity of axial spondyloarthritis (axSpA) in Black Americans.
18 Dec 2024
Estrogen-Progesterone Therapy Linked to Autoimmune Risks
A recent study exploring the impact of estrogen and progesterone analog supplementation on autoimmune conditions reveals a concerning association with several diseases.
17 Dec 2024
Predictors of Psoriatic Arthritis in Juvenile Arthritis
Insights into predicting psoriatic arthritis (PsA) in juvenile idiopathic arthritis (JIA) patients, 18 years after their initial diagnosis, were shared in a recent study.
13 Dec 2024
Treg Cells: Helpers or Harmers in Arthritis?
Regulatory T (Treg) cells are vital for immune system balance, preventing autoimmune diseases by suppressing inflammation.
11 Dec 2024
Is Drug-Free Remission Sustainable In Giant Cell Arteritis?
According to a new study, achieving sustained drug-free remission (SDFR) in giant cell arteritis (GCA) is possible for a significant subset of patients, with low relapse rates once remission is reached.
9 Dec 2024
Infertility Without Treatment Increases Systemic Autoimmune Rheumatic Disease Risk
Females who experience infertility but do not use fertility treatment may be at an increased risk for developing systemic autoimmune rheumatic disease (SARD) after childbirth, according to a new population-based cohort study.
6 Dec 2024
Minimally Invasive Treatment Delays Knee Surgery
Genicular artery embolization (GAE), a minimally invasive procedure, offers promising relief for patients with knee osteoarthritis, potentially delaying or eliminating the need for knee replacement surgery, according to new findings presented at the Radiological Society of North America (RSNA) annual meeting.
4 Dec 2024
Knee Pain Treatment with Colchicine Falls Short
Investigation into colchicine’s potential as a treatment for knee osteoarthritis (OA) found no significant improvement in pain or function in a recent study.
2 Dec 2024
Women with PsA Experience Longer Time to Diagnosis than Men
Women with psoriatic arthritis (PsA) experience longer delays in diagnosis, more intense symptoms, and distinct challenges with treatment compared to men, according to findings presented by Lihi Eder at ACR Convergence 2024.
Loading posts...
« Previous
1
…
17
18
19
20
21
22
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View